Bicycle Therapeutics PLC BCYC:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 05/03/24 EDT
24.58UNCH (UNCH)
Volume
59,824
Close
24.58quote price arrow down-0.11 (-0.45%)
Volume
264,606
52 week range
12.54 - 28.91
Loading...
  • Open25.33
  • Day High25.50
  • Day Low24.53
  • Prev Close24.69
  • 52 Week High28.91
  • 52 Week High Date06/20/23
  • 52 Week Low12.54
  • 52 Week Low Date11/13/23

Key Stats

  • Market Cap933.237M
  • Shares Out37.97M
  • 10 Day Average Volume0.33M
  • Dividend-
  • Dividend Yield-
  • Beta0.90
  • YTD % Change35.95

KEY STATS

  • Open25.33
  • Day High25.50
  • Day Low24.53
  • Prev Close24.69
  • 52 Week High28.91
  • 52 Week High Date06/20/23
  • 52 Week Low12.54
  • 52 Week Low Date11/13/23
  • Market Cap933.237M
  • Shares Out37.97M
  • 10 Day Average Volume0.33M
  • Dividend-
  • Dividend Yield-
  • Beta0.90
  • YTD % Change35.95

RATIOS/PROFITABILITY

  • EPS (TTM)-4.45
  • P/E (TTM)-5.52
  • Fwd P/E (NTM)-4.76
  • EBITDA (TTM)-174.719M
  • ROE (TTM)-56.31%
  • Revenue (TTM)41.61M
  • Gross Margin (TTM)-
  • Net Margin (TTM)-404.14%
  • Debt To Equity (MRQ)8.28%

EVENTS

  • Earnings Date08/01/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Bicycle Therapeutics PLC

 

Profile

MORE
Bicycle Therapeutics plc is a United Kingdom-based clinical-stage biopharmaceutical company. The Company is developing a class of medicines, which it refers to as Bicycles, for diseases that are underserved by existing therapeutics. Bicycles are therapeutic modality combining the pharmacology usually associated with a biologic with the manufacturing and pharmacokinetic properties of a small molecule. Its product candidates BT5528, BT8009 and BT1718, are each a Bicycle Toxin...
Pierre Legault
Non-Executive Chairman of the Board
Kevin Lee Ph.D.
Chief Executive Officer, Executive Director
Alistair Milnes
Chief Operating Officer
Alethia Young M.D.
Chief Financial Officer, Principal Financial Officer
Michael Skynner Ph.D.
Chief Technology Officer
Travis Thompson
Chief Accounting Officer, Principal Accounting Officer
Address
Blocks A & B, Portway Building, Granta P
Cambridge
CB21 6GS
United Kingdom

Top Peers

SYMBOLLASTCHG%CHG
PLX
Protalix Biotherapeutics Inc
1.14-0.02-1.72%
TKNO
Alpha Teknova Inc
1.90-0.04-1.81%
ACRS
Aclaris Therapeutics Inc
1.36+0.05+3.82%
EQ
Equillium Inc
1.67+0.11+7.05%
RPTX
Repare Therapeutics Inc
3.45+0.10+2.99%